Innovation can deliver patient-centric, digitally advanced, resilient and sustainable healthcare ‒ a new video series shows what’s possible if the EU seizes this opportunity for transformation.
The pipeline of new antibiotics to curb the antimicrobial resistance crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives.
Antimicrobial resistance is on the rise, prompting the Swedish government to invite the European Centre for Disease Prevention and Control and the European Commission to review Sweden’s AMR strategy.
An alarming new ECDC survey reveals that healthcare-associated infections (HAI) and antibiotic use are on the rise, increasing patient safety risks across Europe.
A new antibiotic against gram-negative bacteria hasn’t been developed since the 1970s. Now, a European research team led by Swedish scientists has discovered multi-drug-resistant bug-killing compounds that could lead to a new class of antibiotics.
Professor Peter Piot, Belgium’s special advisor to European Commission president Ursula von der Leyen on European and Global Health Security, has called antimicrobial resistance (AMR) a crisis already underway and gaining importance.
x
Researchers at Ireland’s University of Limerick have discovered a new species of bacteria resistant to antibiotics. The discovery was made at UL’s School of Medicine and identified a novel antibiotic-resistant bacterial species capable of colonising patients in a hospital setting.
The EU is falling short of reaching the antimicrobial consumption targets for 2030 with some member states even backtracking from 2019 numbers, a new report by the European Centre for Disease Prevention and Control has found.
While novel antibiotics are critically important in the fight against antimicrobial resistance (AMR), the lack of security and incentives for research and development (R&D) is setting development back, the pharmaceutical industry warns.
When combined with a global approach, cross-country collaboration and measures will be vital to solving the issue of antimicrobial resistance (AMR), according to Health Minister and Deputy Prime Minister of Malta Christopher Fearne in an exclusive interview with Euractiv.
With collective determination, an open mindset and willingness to do things differently, Europe can set an example in the fight against antimicrobial resistance. Huw Tippett, CEO of Shionogi Europe, calls for collective action ahead of the European Health Forum, Gastein.
Members of European Parliament welcomed the proposed revamp of the bloc's regulatory framework for pharmaceuticals during a discussion this week but did not shy away from criticising certain aspects. The Parliament's Public Health Committee (ENVI) this Wednesday (20 September) opened one …
EU health ministers gave the go-ahead to the European Commission’s recommendation to step up EU action to combat antimicrobial resistance (AMR), also welcoming its One Health approach.
The revamp of the bloc's regulatory framework for pharmaceuticals, presented by the European Commission on Wednesday (26 April), features a new and somewhat controversial system of incentives to promote the development of new antimicrobials.
The European Commission will call for "cooperation between different stakeholders to bring about positive change" in the pharmaceutical sector, according to a leaked communication accompanying the revision of the EU's drug framework.
With only a few weeks before unveiling the EU's revamped framework for pharmaceuticals, Health Commissioner Stella Kyriakides described the main drivers of the much-awaited reform, stressing the importance of finding the balance between patients' and industry's interests.
The start of 2023 saw the EU's new agricultural policy come into force in Germany, alongside new animal husbandry rules. However, some of German Agriculture Minister Cem Özdemir's core projects remain in the planning phase.
Partnership to Fight Infectious Disease, a non-profit group of patients, providers, community organizations, academic researchers, business and labor groups, and infectious disease experts shares its reaction to DG SANTE’s Global Health Strategy and key considerations such as the research and development pipeline for antibiotics, and global supply of antibiotics.
Sales of antibiotics used for animal use have almost halved between 2011-2021, according to a new report issued by the European Medicines Agency (EMA), putting the EU on track to attain its ambitions, but with a warning that the sector should not become complacent.
Medical technologies can help to reduce infection risks, contain outbreaks and support antimicrobial stewardship. It is time for a broader view with more emphasis on prevention.
Animal transportation times should be cut to reduce the risk of spreading antimicrobial resistance, according to a new scientific opinion from the European Food Safety Authority (EFSA).
The European Health Union indicated antimicrobial resistance (AMR) as one of its top three priority health threats in the EU on Tuesday (12 July) - the same day as the WHO called for accelerating of development of AMR-related vaccines.
The COVID-19 crisis has underscored that there is no way to ensure human and animal health without wider consideration of environmental health, Monique Eloit, Director General of the World Organisation for Animal Health, told EURACTIV in an interview.
